IL22 and Alzheimer disease: While the role of IL-22 in driving epidermal hyperplasia and barrier dysfunction in AD is well established, the functional stratification of IL-22–producing patients with moderate-to-severe AD in response to a disease-relevant trigger has not been previously described.